Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Oct;51(10):110346.
doi: 10.1016/j.ejso.2025.110346. Epub 2025 Jul 28.

Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASE

Clara Naessens  1 , Cécile Evin  2 , Karine Le-Malicot  3 , Claire Lemanski  4 , Magali Rouffiac  5 , David Tougeron  6 , Laurent Quero  7 , Mounira El Demery  8 , Ludovic Evesque  9 , Laurent Alcaraz  10 , Mathieu Minsat  11 , Astrid Lièvre  12 , Franck Drouet  13 , Vincent Hautefeuille  14 , Laurianne Plastaras  15 , Elodie Menager-Tabourel  16 , Nabil Baba-Hamed  17 , Philippe Ronchin  18 , Anne-Agathe Serre  19 , Christophe Locher  20 , Christelle De la Fouchardière  21 , Florence Huguet  2 , Véronique Vendrely  22
Affiliations
Multicenter Study

Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASE

Clara Naessens et al. Eur J Surg Oncol. 2025 Oct.

Abstract

Introduction: Salvage abdominoperineal resection (APR) is indicated for local failure following definitive chemoradiotherapy or radiotherapy for squamous cell carcinoma (SCCA), at the cost of morbidity and reduced quality of life. This study evaluated outcomes after salvage APR.

Materials and methods: The FFCD-ANABASE cohort is a prospective multicenter cohort including patients treated for non-metastatic SCCA in France between 2015 and 2020. Among the 1015 patients included in FFCD-ANABASE, 78 underwent salvage APR. After excluding patients with a pathological complete response (pT0N0), the final efficacy analysis cohort comprised 66 patients. We analyzed disease-free survival (DFS), overall survival (OS), locoregional and metastatic relapse rates, post-operative morbidity and prognostic factors in patients who underwent salvage APR for local failure.

Results: With a median follow-up of 58.6 months after APR, the locoregional relapse rate was 21.2 % and the metastatic relapse rate was 9.1 %. An R0 resection was achieved in 80.8 % of cases. Five-year DFS and OS rates were 45.8 % [95 %CI: 33.3-57.4], and 50.2 % [95 %CI: 37.1-62.0]. In multivariate analysis, R0 margins (HR: 0.24 [95 %CI: 0.10-0.61]), and tumor size before chemoradiotherapy <4 cm (HR: 0.33 [95 %CI: 0.12-0.91]) were associated with better DFS; whereas no factor was significantly associated with OS. Post-operative morbidity was reported in 65 patients (83.3 %), with 34 of them (52.3 %) experiencing major complications, classified as Clavien-Dindo III-V.

Conclusions: Salvage APR results in high post-operative morbidity and poor oncological outcomes. Our study found that complete resection margins was favorable prognostic factor, suggesting the need for additional perioperative treatment.

Keywords: Abdominoperineal resection; Anal cancer; Chemoradiotherapy; Salvage surgery; Squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Publication types

MeSH terms